The cell division cycle-associated gene (CDCA3), mRNA, and protein expressions were increased in NSCLC compared with normal tissue, and high levels of CDCA3 was associated with poor prognosis in Adams et al. [69].The mRNA and protein expressions of numerous network genes were associated with drug sensitivity or resistance to 10 commonly used therapeutic regimens for treating NSCLC. Here, CDCA3 is linked to non-small cell lung carcinoma.